Your browser doesn't support javascript.
loading
Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML.
Lancet, Jeffrey E; Cortes, Jorge E; Hogge, Donna E; Tallman, Martin S; Kovacsovics, Tibor J; Damon, Lloyd E; Komrokji, Rami; Solomon, Scott R; Kolitz, Jonathan E; Cooper, Maureen; Yeager, Andrew M; Louie, Arthur C; Feldman, Eric J.
Afiliación
  • Lancet JE; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;
  • Cortes JE; University of Texas MD Anderson Cancer Center, Houston, TX;
  • Hogge DE; British Columbia Cancer Agency, Vancouver, BC, Canada;
  • Tallman MS; Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY;
  • Kovacsovics TJ; Oregon Health & Science University, Knight Cancer Institute, Portland, OR;
  • Damon LE; University of California, San Francisco, San Francisco, CA;
  • Komrokji R; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;
  • Solomon SR; Blood & Marrow Transplant at Northside Hospital, Atlanta, GA;
  • Kolitz JE; Hofstra North Shore-Long Island Jewish School of Medicine, Lake Success, NY;
  • Cooper M; St. Francis Hospital and Health Centers, Indianapolis, IN;
  • Yeager AM; University of Arizona, Tucson, AZ;
  • Louie AC; Celator Pharmaceuticals, Inc., Princeton, NJ; and.
  • Feldman EJ; Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, NY.
Blood ; 123(21): 3239-46, 2014 May 22.
Article en En | MEDLINE | ID: mdl-24687088

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Citarabina / Antibióticos Antineoplásicos / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2014 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Citarabina / Antibióticos Antineoplásicos / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2014 Tipo del documento: Article